A detailed history of Sit Investment Associates Inc transactions in Amgen Inc stock. As of the latest transaction made, Sit Investment Associates Inc holds 750 shares of AMGN stock, worth $237,000. This represents 0.01% of its overall portfolio holdings.

Number of Shares
750
Previous 1,075 30.23%
Holding current value
$237,000
Previous $306,000 23.53%
% of portfolio
0.01%
Previous 0.01%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$262.75 - $319.31 $85,393 - $103,775
-325 Reduced 30.23%
750 $234,000
Q1 2024

May 14, 2024

BUY
$268.87 - $324.56 $30,920 - $37,324
115 Added 11.98%
1,075 $306,000
Q4 2023

Feb 13, 2024

SELL
$255.7 - $288.46 $12,785 - $14,422
-50 Reduced 4.95%
960 $276,000
Q2 2023

Aug 10, 2023

SELL
$214.27 - $253.37 $16,070 - $19,002
-75 Reduced 6.91%
1,010 $224,000
Q1 2023

May 11, 2023

BUY
$225.79 - $275.2 $48,544 - $59,168
215 Added 24.71%
1,085 $262,000
Q4 2022

Feb 10, 2023

BUY
$229.03 - $291.01 $199,256 - $253,178
870 New
870 $228,000
Q4 2020

Feb 11, 2021

SELL
$216.38 - $257.67 $4.96 Million - $5.91 Million
-22,945 Closed
0 $0
Q3 2020

Nov 12, 2020

SELL
$234.65 - $260.95 $1.37 Million - $1.53 Million
-5,850 Reduced 15.29%
32,400 $6.27 Million
Q3 2020

Nov 12, 2020

SELL
$234.65 - $260.95 $2.22 Million - $2.47 Million
-9,455 Reduced 29.18%
22,945 $5.83 Million
Q2 2020

Aug 13, 2020

SELL
$197.81 - $242.74 $217,591 - $267,014
-1,100 Reduced 2.8%
38,250 $9.02 Million
Q1 2020

May 13, 2020

BUY
$182.24 - $241.7 $1.19 Million - $1.58 Million
6,550 Added 19.97%
39,350 $7.98 Million
Q4 2019

Feb 13, 2020

BUY
$189.21 - $243.2 $75,684 - $97,280
400 Added 1.23%
32,800 $7.91 Million
Q3 2019

Nov 13, 2019

SELL
$174.11 - $208.62 $1.46 Million - $1.75 Million
-8,385 Reduced 20.56%
32,400 $6.27 Million
Q2 2019

Aug 14, 2019

SELL
$166.7 - $195.41 $3.14 Million - $3.68 Million
-18,850 Reduced 31.61%
40,785 $7.52 Million
Q1 2019

May 14, 2019

SELL
$180.87 - $203.88 $3.71 Million - $4.19 Million
-20,530 Reduced 25.61%
59,635 $11.3 Million
Q4 2018

Jan 14, 2019

SELL
$178.4 - $208.25 $3.34 Million - $3.9 Million
-18,710 Reduced 18.92%
80,165 $15.6 Million
Q3 2018

Nov 14, 2018

BUY
$185.29 - $208.89 $5.24 Million - $5.91 Million
28,284 Added 40.07%
98,875 $20.5 Million
Q2 2018

Jul 19, 2018

BUY
$166.05 - $186.51 $11.7 Million - $13.2 Million
70,591 New
70,591 $13 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $169B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Sit Investment Associates Inc Portfolio

Follow Sit Investment Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sit Investment Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Sit Investment Associates Inc with notifications on news.